The Trump administration has finalized a significant increase in payment rates for Medicare Advantage plans, boosting average payments by 2.48%—a move that translates to over $13 billion in 2027. This decision marks a stark contrast to the initial proposal of just 0.09% earlier this year, which had negatively impacted health insurer stocks. Following the announcement, shares of major players like UnitedHealth and CVS Health surged over 9% in after-hours trading, while Humana’s stock soared approximately 12%.
This payment rate adjustment is critical for health insurers as it directly influences their ability to set monthly premiums and benefits, thereby impacting profitability. With more than half of Medicare beneficiaries enrolled in these plans, the increase is expected to enhance the affordability and attractiveness of Medicare Advantage, potentially driving enrollment and revenue growth for insurers.
Market professionals should note that this development could lead to a sustained rally in health insurer stocks, as improved payment rates may bolster earnings forecasts and investor sentiment in the sector.
Source: cnbc.com